- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Brivaracetam – March 2017
Brivaracetam: Tablet 25 mg, Table 50 mg, Tablet 75 mg, Tablet 100 mg, Oral suspension 10 mg per mL, 300 mL; Briviact®
Last updated
30 June 2017